Montoya, A., Amaya, C. N., Belmont, A., Diab, N., Trevino, R., Villanueva, G., . . . Nahleh, Z. (2016). Use of non-selective β-blockers is associated with decreased tumor proliferative indices in early stage breast cancer. Oncotarget.
Citação norma ChicagoMontoya, Alexa, et al. "Use of Non-selective β-blockers Is Associated With Decreased Tumor Proliferative Indices in Early Stage Breast Cancer." Oncotarget 2016.
ציטוט MLAMontoya, Alexa, et al. "Use of Non-selective β-blockers Is Associated With Decreased Tumor Proliferative Indices in Early Stage Breast Cancer." Oncotarget 2016.
אזהרה: ציטוטים אלה לעיתים לא מדויקים ב 100%.